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Abstract
Background: Elevated C-reactive protein (CRP) level is widely used in clinical practice as a marker to distinguish
between neonates with or without sepsis. However, some neonates with bacteremia have a CRP level within the
normal range and they are not well characterized.
Methods: All episodes of neonatal culture-proven bloodstream infections (BSIs) between July 2004 and June 2012
were enrolled. Patients characteristics were compared for three CRP groups (low, ≤ 10 mg/L; intermediate,
11–100 mg/L; and high, > 100 mg/L) using the Chi-square test and one-way ANOVA. The sepsis-attributable mortality
rates were compared using logistic regression analyses.
Results: Of 986 episodes of neonatal BSI, 247 (25.1 %) had CRP ≤10 mg/L at the onset of clinical sepsis. In the low CRP
group, patients had lower gestational age and birth weight, and an earlier occurrence of BSI. Patients with underlying
gastrointestinal pathology, renal disorders, cholestasis, and pulmonary hypertension had a non-significant elevated CRP
level at the onset of sepsis. In the blood culture of the low CRP group, coagulase-negative staphylococci (CoNS)
were relatively more common (55.9 %, p < 0.001) than the other two groups, although one-fourth were infected with
gram-negative bacilli (19.0 %), fungi (2.8 %), or polymicrobial pathogens (3.6 %). Of the BSIs with initial low CRP, 29.1 %
were treated with inadequate antibiotics, 13.0 % progressed to septic shock, and 5.3 % had infectious complications.
The sepsis-attributable mortality rate was lower in the low CRP group (4.9 %) than in the high CRP group (13.6 %).
Conclusions: A considerable proportion of neonatal BSIs had a normal or low initial CRP level (≤10 mg/L), which was
more likely to occur in low birth weight or extremely preterm infants, those with earlier onset of sepsis, and those
infected with CoNS. Plasma CRP level should not be used to rule out severe culture-proven sepsis or guide the
empirical choice of antibiotics.
Background
The incidence of culture-proven bloodstream infection
(BSI) in the neonatal intensive care unit (NICU) is
around 37 episodes per 10,000 neonate-hospital days
[1–4]. Neonatal BSI is associated with significant morbid-
ity, worse long-term outcomes, and a reported mortality
rate of 12–20 % [1, 5–8]. Early and appropriate anti-
biotic treatment is the cornerstone of treatment [9, 10],
which highlights the importance of a high index of
suspicion based on clinical and laboratory parameters
long before the blood culture results are known. How-
ever, some neonatal BSIs may present with nonspecific
symptoms and several laboratory predictors have been
investigated for better identification of bacteremia in
the NICU [11–15].
C-reactive protein (CRP) is an acute-phase protein of
hepatic origin that increases following interleukin-6
secretion from macrophages and T-cells [16, 17]. The
synthesis of CRP in response to inflammation starts very
rapidly, and serum concentration rises to > 5 mg/L after
6 h and peaks at 48 h [18, 19]. The CRP reference values
in neonates reported in the literature are 1.5–20 mg/L
and have a wide range of sensitivities and specificities
[19, 20]. Although some studies have demonstrated that
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at least 2 CRP levels, both ≤ 10 mg/L and obtained 24 h
apart, are needed to identify infants unlikely to be in-
fected [19, 21], the high cut-off value associated with
bacterial infection in neonates is still uncertain. Con-
versely, a small proportion of patients with bacteremia
have CRP levels within the normal range [22, 23]. To
date, this issue has not been well studied in the NICU.
The present study was therefore conducted to characterize
outcomes in neonates with culture-proven BSI and a CRP
plasma level ≤ 10 mg/L.
Methods
We identified all episodes of culture-proven BSI in the
NICU of Chang Gung Memorial Hospital (CGMH), a
tertiary-level medical center in a university-affiliated
teaching hospital in northern Taiwan, between 1 July
2004 and 30 June 2012. Only infants with late-onset
sepsis, defined as clinical sepsis with a positive blood
culture obtained after 3 days of life [1, 3, 24], were
enrolled. The NICU has 3 units that include 49 beds
equipped with mechanical ventilators and 28 beds in
special-care nurseries. All babies under 34–35 weeks
of completed gestation or birth weight < 2 kg or > 5 kg
or those with any clinical signs of respiratory distress or
cardiovascular, gastrointestinal, or neurological problems
requiring surgical or intensive treatment were eligible for
admission to our NICU. This study was approved by the
institutional review board of Chang Gung Memorial
Hospital, with a waiver of informed consent because all
patient records/information was anonymized and de-
identified prior to analysis.
Data retrieval and study database
Information for the NICU database was recorded by a
full-time nurse specialist dedicated to following up neo-
nates from birth (or admission if the neonate was trans-
ferred from another hospital) until discharge or death,
and this nurse specialist has maintained the database
every weekday for > 10 y. The NICU database contained
information about basic demographic data, a summary
of the patient’s hospital course, discharge diagnosis, and
complications during prematurity. Medical records were
reviewed to characterize the detailed courses of every
episode of BSI, including the clinical manifestations,
laboratory results, progression of septic conditions,
concurrent infectious focus, treatment, infectious com-
plications, and outcomes. The severity of illness was
evaluated at the most severe period during the course
of BSI using the neonatal therapeutic intervention
scoring system (NTISS) [25].
Definitions
An episode of BSI was defined according to the pres-
ence of clinical sepsis and identification of pathogens,
which included any bacteria isolated from at least
one blood culture and not pertaining to the sapro-
phytic skin flora as significant. Growth of Corynebac-
terium spp., Propionibacterium spp., Penicillium spp.,
or Diphtheroids spp. in the blood cultures were consid-
ered contaminants and were excluded. The microbiol-
ogy assay system in our hospital is a matrix-assisted
laser desorption ionization time-of-flight (MALDI-TOF)
system (Bruker’s flagship FLEX series). For coagulase-
negative staphylococci (CoNS) BSI, the diagnosis re-
quired clinical signs of sepsis, a blood culture positive
for CoNS, and administration of intravenous antibac-
terial therapy for at least 5 days after the blood culture
or until death [1, 2, 7].
An episode of clinical sepsis was defined if a patient
had a positive blood culture treated with antibiotic
therapy for 5 or more days or treated for a shorter
period if the patient died, and the presence of at least
two of the following clinical symptoms of sepsis: fever
or hypothermia, hyper- or hypoglycemia, apnea or
tachypnea, frequent desaturation with an increased re-
quirement for ventilator support, bradycardia and/or
cyanosis, feeding intolerance, abdominal distension, seizure,
decreased activity, skin mottling and hypotension [1, 7, 9].
All co-morbidities of prematurity, including respiratory
distress syndrome (RDS), intra-ventricular hemorrhage
(IVH), broncho-pulmonary dysplasia (BPD), necrotizing
enterocolitis (NEC), and peri-ventricular leukomalacia
(PVL) were based on the latest updated diagnostic cri-
teria [26]. Congenital anomalies included all neonates
with either documented or undocumented syndrome,
chromosome abnormalities, and genetic or metabolic
disorders, but not simple cleft palate or polydactyly.
Persistent bacteremia or fungemia was defined as three
or more consecutive positive blood cultures, at least
48 h apart, during a single episode of sepsis [27]. All
concurrent infectious foci, including NEC, ventilator
associated pneumonia (VAP), catheter-related blood-
stream infection (CRBSI), or meningitis were also re-
corded based on the strict diagnostic criteria of the
Centers for Disease Control and Prevention and previ-
ous official publications [28, 29].
Infectious complications were defined as a new-onset
infectious focus, empyema, abscess, venous thrombosis,
or vegetation directly related to bacteremia or major
organ dysfunction within 1 week after the onset of
bacteremia. Empirical antibiotic therapy was considered
inappropriate if the treatment regimen did not include
at least 1 antibiotic active in vitro against the infecting
microorganisms administered within 24 h of blood culture
collection. For patients who died during hospitalization,
the cause of death was recorded according to the clini-
cian’s assessment. Sepsis-attributable mortality was de-
fined as neonates who expired within 3 days after the
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onset of sepsis and those who died of infectious complica-
tions or clinically progressive deterioration following the
onset of BSI.
Data on CRP
The CRP plasma level was measured with an immuno-
turbidimetric instrument (Modular P, Roche, Germany).
We excluded episodes of BSI for which CRP was not
measured on the date of BSI onset. If more than 1 CRP
measurement was done on the date of BSI, we used the
measurement conducted closest to the time when blood
culture samples were drawn. In the laboratory, a CRP
level ≤ 5 mg/L was considered within the normal
range. The low limit of detection of CRP in our hos-
pital is > 0.5 mg/L, and there is no upper limit of CRP
detection. All BSI episodes were divided into 3 CRP
groups: low (CRP ≤ 10 mg/L), intermediate (CRP 11–
100 mg/L), and high (CRP > 100 mg/L).
Statistical analysis
The patient characteristics by CRP group were com-
puted in contingency tables. Differences in categorical
and continuous variables were tested by the χ2 test and
one-way ANOVA, respectively. For continuous vari-
ables with large standard deviations, the nonparametric
Kruskal–Wallis H test was applied. Trends in propor-
tions of microorganisms in the 3 CRP groups were ana-
lyzed using the χ2 test for trend. Statistical significance
was set at P < 0.05.
The sepsis-attributable mortality rate by CRP group
was examined using a logistic regression model. Uni-
variate and multivariate analyses, including the co-
variables of sex, gestational age, underlying chronic
co-morbidities, and bacterial subgroups, were per-
formed. Because of the strong correlation between
birth weight and gestational age, the risk factor of
body weight at birth was excluded from the analysis.
Estimates were expressed as odds ratios (ORs) with 95 %
confidence intervals (CIs). All statistical analyses were per-
formed using SPSS version 15.0 (SPSS, Chicago, IL, USA).
Results
During the study period, 1010 episodes of BSI (late-on-
set sepsis) in 793 neonates from the NICU were identi-
fied. Those with incomplete medical records (n = 8), no
CRP measurement at BSI onset (n = 12), or transfer to
another hospital (n = 4) were excluded, leaving a total of
986 BSI episodes in 772 neonates. Among these, 247
(25.1 %) had a plasma CRP level ≤ 10 mg/L, 563 (57.1 %)
had a plasma CRP level of 11–100 mg/L, and 176
(17.8 %) had a plasma CRP level > 100 mg/L.
Patients in the low CRP group had a lower birth
body weight and gestational age and an earlier onset of
BSI than patients in the intermediate and high CRP
groups (Table 1). There were no significant differences
in the perinatal history and most underlying chronic
co-morbidities among the 3 CRP groups. However,
patients with gastrointestinal pathology, pulmonary
hypertension, renal disorders, or cholestasis were more
likely to have high CRP at BSI onset. When the clinical
symptoms or signs were compared, significantly more
patients in the high CRP group had apnea, bradycardia
with or without cyanosis, feeding intolerance, hyper-
or hypoglycemia, or septic shock compared to those in
the low CRP group (Table 1). These clinical symptoms
were not significantly different between the low and
intermediate CRP groups.
Episodes of BSI in the high CRP group had a signifi-
cantly higher rate of abnormal laboratory findings, in-
cluding leucopenia, anemia, thrombocytopenia, and
metabolic acidosis compared to those in the low CRP
group. The severity of illness, judged by NTISS score,
was also significantly higher in the high CRP group than
in the low CRP group. These demographics, clinical
features, and laboratory findings were not significantly
different between neonatal BSIs in the low and inter-
mediate CRP groups as determined by post hoc analyses
(data not shown). However, neonatal BSIs in the low
CRP groups occurred significantly earlier than in both
the intermediate and high CRP groups. Episodes of BSI
with concurrent meningitis, ventilator-associated pneu-
monia, and catheter-related BSI also had elevated CRP
at the onset of clinical sepsis (Table 1).
Microbiology
In the low CRP group, gram-positive, gram-negative,
fungal, and polymicrobial pathogens accounted for 74.5,
19.0, 2.8, and 3.6 % of infections, respectively. CoNS was
significantly more common in the blood cultures of the
low CRP group compared to the other groups. A lower
proportion of most gram-negative bacteria occurred in
the low CRP group (Table 2). However, for gram-
positive bacteria, there were significantly fewer patients
with Group B Streptococcus BSI and comparable num-
bers of Staphylococcus aureus BSI in the low CRP group.
Of the 247 patients with an initial plasma CRP
level ≤ 10 mg/L, 178 had at least 1 more CRP measure-
ment during the days following BSI onset. Among
these, 82 (46.1 %) developed a CRP response > 10 mg/L
(median [IQR]: 35.0 mg/L [22.8–52.5 mg/L]) at a
median of 2.8 days (range 1–7 days) after antibiotic
treatment. Of the 138 episodes of CoNS BSI with an
initial CRP plasma level ≤ 10 mg/L, 58 (42.0 %) were
treated with initial antibiotics that were inadequate
and had repeated positive blood cultures. Among the
96 episodes of neonatal BSIs with repeated CRP data
that still had a CRP level ≤ 10 mg/L, 31 (32.3 %) had
CoNS in their blood cultures.
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Table 1 Episodes of bloodstream infection stratified according to low (CRP 0–10 mg/L), intermediate (CRP 11–100 mg/L) and high
(CRP > 100 mg/L) level
Characteristics CRP 0–10 mg/L (n = 247) CRP 11–100 mg/L (n = 563) CRP > 100 mg/L (n = 176) p value
Demographic characteristics
Birth weight (g), mean ± SD 1310 ± 746 1507.9 ± 809 1725.2 ± 959 0.004
median (IQR) 1310 (920–1740) 1530 (885–1975) 1685 (923–2610)
Gestational age (weeks), mean ± SD 30.2 ± 4.3 30.5 ± 4.6 31.4 ± 5.2 0.036
median (IQR) 30.0 (27.0–33.0) 30.0 (27.0–34.0) 30.0 (27.0–36.0)
Male sex, n (%) 140 (56.7) 292 (51.9) 88 (50.0) 0.154
Onset of BSI (day), median (IQR) 23.0 (15.0–43.0) 30.0 (18.0–56.0) 32.5 (19.0–63.8) <0.001
Perinatal history
NSD/CS 112 (45.3)/135 (54.7) 220 (39.1)/343 (60.9) 81 (46.0)/95 (54.0) 0.901
Inborn/outborn 163 (66.0)/84 (34.0) 381 (67.7)/182 (32.3) 112 (63.6)/64 (36.4) 0.697
Low apgar score at 5 min (≦7) 111 (44.9) 255 (45.3) 70 (39.8) 0.344
Perinatal asphyxia 18 (7.3) 48 (8.5) 11 (6.3) 0.738
Underlying chronic conditionsa
Congenital anomalies 15 (6.1) 35 (6.2) 18 (10.2) 0.128
Neurological comorbidities 35 (14.2) 63 (11.2) 31 (17.6) 0.443
Complicated congenital heart disease (CHD) 8 (3.2) 23 (4.1) 4 (2.3) 0.696
Acyanotic CHD with heart failure 5 (2.0) 9 (1.6) 7 (4.0) 0.234
Bronchopulmonary dysplasia 66 (26.7) 188 (33.4) 60 (34.1) 0.087
Pulmonary hypertension 3 (1.2) 18 (3.2) 11 (6.3) 0.004
Gastrointestinal pathology 4 (1.6) 47 (8.3) 15 (8.5) 0.002
Renal 6 (2.4) 17 (3.0) 12 (6.8) 0.024
Cholestasisb 30 (12.1) 117 (20.8) 41 (23.3) 0.002
Clinical septic symptoms
Fever (temperature > 38 °C) 99 (40.1) 228 (40.5) 84 (47.7) 0.135
Apnea ± bradycardia and/or cyanosis 158 (64.0) 385 (68.4) 139 (79.0) 0.001
Abdominal distension ± feeding intolerance 130 (52.6) 328 (58.3) 139 (79.0) <0.001
Tachycardia 55 (22.3) 134 (23.8) 35 (19.9) 0.652
Hyper- or hypoglycemia 53 (21.5) 157 (27.9) 55 (31.3) 0.020
Septic shock 32 (13.0) 93 (16.5) 45 (25.6) 0.001
Disseminated intravascular Coagulopathy 12 (4.9) 45 (8.0) 30 (17.0) <0.001
Laboratory parameter
Leukopenia (WBC count < 4000/uL) 25 (10.1) 109 (19.4) 38 (21.6) 0.001
Leukocytosis (WBC count > 20,000/uL) 62 (25.1) 151 (26.8) 64 (36.4) 0.017
WBC shift to left (immature WBC≥ 20 % total) 13 (5.3) 65 (11.5) 44 (25.0) <0.001
Anemia (hemoglobin < 11.0 mg/dL) 79 (32.5) 217 (38.5) 98 (55.7) <0.001
Thrombocytopenia (platelet < 80,000/uL) 41 (16.6) 197 (35.0) 110 (62.5) <0.001
Metabolic acidosis 26 (10.7) 104 (18.5) 60 (34.1) <0.001
Prolonged PT and/or aPTT 34 (14.0) 150 (26.6) 70 (39.8) <0.001
NTISS score, mean ± SD 16.3 ± 4.2 16.9 ± 4.6 18.2 ± 5.1 <0.001
Sequences of BSI during hospitalization 0.014
First episode 204 (82.6) 412 (73.2) 128 (72.7)
2nd episode 29 (11.7) 95 (16.9) 31 (17.6)
>2nd episode 14 (5.7) 56 (9.9) 17 (9.7)
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Treatments and outcomes
Neonates who experienced BSI episodes and had
higher CRP levels had significantly more invasive in-
tubation or high-frequency oscillatory ventilator use
(Table 3). The rates of inadequate antibiotic treatment
were comparable among the 3 CRP groups. The over-
all sepsis-attributable mortality rate was 7.4 % and oc-
curred in 4.9, 6.6, and 13.6 % in the low, intermediate,
and high CRP groups, respectively. Neonates in the
high CRP group had a significantly higher sepsis-
attributable mortality compared with those in the
intermediate and low CRP groups (P < 0.05 by log-rank
test) (Fig. 1).
There was no difference in the sepsis-attributable mor-
tality rate between those with CRP ≤ 10 mg/L and those
with CRP of 11–100 mg/L. The CRP level was a pre-
dictor of sepsis-attributable mortality (OR 3.09, 95 % CI
1.50–6.37) in the high CRP group compared to the low
CRP group. The difference between these 2 groups
remained unchanged even after adjustments for birth
weight, sex, gestational age, bacterial subgroups, and
several underlying chronic morbidities (data not shown).
Discussion
Approximately one-fourth of the cases of neonatal
BSI—which is a surprisingly high proportion in the
Table 1 Episodes of bloodstream infection stratified according to low (CRP 0–10 mg/L), intermediate (CRP 11–100 mg/L) and high
(CRP > 100 mg/L) level (Continued)
Concomitant infectious focusc
Meningitis 12 (4.9) 20 (3.6) 23 (13.1) 0.001
Catheter-related bloodstream infection 12 (4.9) 30 (5.3) 20 (11.4) 0.012
Necrotizing enterocolitis (≥ stage II)d 4 (1.6) 10 (1.8) 7 (4.0) 0.126
Ventilator associated pneumonia 7 (2.8) 18 (3.2) 15 (8.5) 0.007
Otherse 1 (0.4) 3 (0.5) 3 (1.7) -
All data were expressed as number (percentage %), unless indicated otherwise
NTISS neonatal therapeutic intervention scoring system, IQR interquartile range, SD standard deviation, BSI bloodstream infection, NSD natural vaginal delivery, C/S
cesarean section
aIndicating the presence of chronic conditions or comorbidities at onset of bloodstream infection, and some patients had > 1 underlying chronic conditions. Each
patient with an underlying chronic condition is compared with those without that specific condition
bIndicating direct bilirubin ≥ 1.5 mg/dL or more than 50 % of the total bilirubin
cIndicating the diagnosis of a infectious focus was concurrent with onset of bacteremia
dBased on modified Bell’s staging criteria
eIncluded osteomyelitis (2), septic arthritis (2), left thigh cellulitis (1), and urinary tract infection (2)
Table 2 Pathogens causing neonatal bloodstream infections in the three CRP groups
Pathogens CRP 0–10 mg/L (n = 247) CRP 11–100 mg/L (n = 563) CRP > 100 mg/L (n = 176) P value
Gram-positive organisms 184 (74.5) 322 (57.2) 63 (35.8) <0.001
Coagulase-negative staphylococci (CoNS) 138 (55.9) 227 (40.3) 24 (13.6) <0.001
Staphylococcus aureus 34 (13.8) 62 (11.0) 23 (13.1) 0.715
Enterococcus spp. 8 (3.2) 18 (3.2) 1 (0.6) 0.130
Group-B streptococcus 3 (1.2) 13 (2.3) 15 (8.5) <0.001
Othersa 1 (0.4) 2 (0.4) 0 (0) -
Gram-negative organisms 47 (19.0) 174 (30.9) 91 (51.7) <0.001
E coli 12 (4.9) 41 (7.3) 23 (13.1) 0.003
Klebsiella spp. 18 (7.3) 66 (11.7) 32 (18.2) 0.001
Enterobacter spp. 4 (1.6) 26 (4.6) 11 (6.3) 0.015
Acinetobacter baumannii 6 (2.4) 23 (4.1) 12 (6.8) 0.028
Pseudomonas spp. 3 (1.2) 6 (1.1) 6 (3.4) 0.103
Serratia marscences 3 (1.2) 7 (1.2) 1 (0.6) 0.574
Othersb 2 (0.8) 5 (0.9) 6 (3.4) 0.113
Fungemia 7 (2.8) 38 (6.7) 11 (6.3) 0.090
Polymicrobial bloodstream infection 9 (3.6) 29 (5.2) 11 (6.3) 0.214
aIncluding Streptococcus pneumonia (1), and non-enterococcal group D streptococcus (2)
bIncluding Citrobacter freundii (3), Stenotrophomonas maltophilia (3), Hafnia alvei (2), Neisseria Meningitidis (2), Chryseobacterium meningoseptium (1)
Flavobacterium (1) and Morganella morganii (1)
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current cohort—had a CRP level of ≤ 10 mg/L at the
onset of clinical sepsis. Low birth weight neonates, very
low gestational age infants, and those in whom the oc-
currence of BSI episodes occurred earlier in life were
more likely to have normal CRP at the onset of clinical
sepsis. We found a high CRP level (>100 mg/L) was
significantly associated with more severe clinical symp-
toms and worse outcomes. Although CoNS accounts
for more than half of the episodes of BSI with normal
CRP, in our cohort approximately one-fourth of those
with normal CRP were infected with gram-negative
bacteria, polymicrobial pathogens, or fungus. Further-
more, approximately 30 % of those with normal CRP
were treated with inadequate initial antibiotics, and
13 % progressed to septic shock and 4.9 % had sepsis-
attributable mortality.
It is reasonable to hypothesize that causative patho-
gens affect CRP level because some pathogens, especially
gram-negative bacilli or Pseudomonas spp., tend to have
a fulminant course [1, 7, 9], which can result in more se-
vere tissue damage and inflammation. The findings here
are consistent with a recent study conducted by Knudt-
zen et al., who found that CoNS BSI is more common in
the low CRP group and that approximately 25–35 % of
all CoNS BSI have normal CRP at the onset of clinical
sepsis [22]. Because drawing 2 sets of blood culture at
the same time is not routinely done and the second
blood culture may become negative if vancomycin was
Table 3 Treatment and outcomes of neonatal bloodstream infections among the three CRP groups
CRP 0–10 mg/L (n = 247) CRP 11–100 mg/L (n = 563) CRP > 100 mg/L (n = 176) P value
Treatment
Invasive intubation 106 (42.9) 254 (45.1) 95 (54.0) 0.042
High frequency oscillatory ventilator 18 (7.3) 57 (10.1) 25 (14.2) 0.021
Inadequate antibiotic treatment with the first 24 h 72 (29.1) 150 (26.6) 42 (23.9) 0.463
Outcomes
Infectious complications 13 (5.3) 49 (8.7) 42 (23.9) <0.001
Sepsis attributable mortality 12 (4.9) 37 (6.6) 24 (13.6) 0.001
Fig. 1 Survival following positive blood culture from 986 episodes of neonatal culture-proven bloodstream infection. The Kaplan-Meier graph is
stratified by three different CRP groups: low, ≤ 10 mg/L; intermediate, 11–100 mg/L; and high, > 100 mg/L
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initially administrated, the lack of 2 positive blood cul-
tures for documentation of CoNS BSI is a limitation of
this study. Some possibly represent bacterial contami-
nations. To reduce the false positive cases of CoNS
BSI, strict criteria for CoNS BSI have been applied, in-
cluding requiring more than 2 septic symptoms or
signs, as in previous studies [1, 2, 8]. Besides, more
than three-fourths of the CoNS BSIs have elevated
CRP or abnormal laboratory findings.
Because the initial symptoms of neonatal sepsis may
be nonspecific and subtle and may become fulminant if
appropriate antibiotics are not administered in time,
the role of plasma CRP level in adequately predicting
serious bacterial infection in neonates has recently be-
come the topic of several studies [30–33]. Although we
found that significantly more infectious complications
and sepsis-attributable mortality occurred in the CRP
group with > 100 mg/L, a possibly delayed elevation
and inadequate sensitivity of CRP testing highlight the
importance of investigating other predictors, including
new laboratory markers [30–35] and clinical scores
[36–38] and maintaining high alertness for the develop-
ment of severe sepsis. Several studies report a sensitivity
and specificity of 48–78 % and 71–88 %, respectively, for a
single determination of CRP at 4–12 h after symptom on-
set [31–35]. Therefore, taken together, using the CRP level
as a guide for empirical choice of antibiotics or to rule out
serious infections or withhold antibiotic therapy is not
recommended.
This study also investigated whether BSI episodes with
initially low CRP levels developed a CRP response later.
In contrast to a recent study in which 84 % of BSIs with
initially normal CRP mounted a CRP response [22], the
current study reveals that only 46 % have elevated subse-
quent CRP. This may be due to the high rate of initial
effective antibiotic therapy and, possibly, the presence of
CoNS as a low-level pathogenic bacterium that causes
less tissue damage and inflammation. In a cohort of 60
neonates with early-onset sepsis, Ehl et al. [39] demon-
strated that the CRP values decrease 16 h after success-
ful antibiotic therapy. Some cases without CRP response
in our cohort presented with a very fulminant course
and hepatic failure, which was similar to a finding in a
previous study [40].
The value of CRP as a predictive marker for bacterial
infection in neonates has been studied with varying re-
sults [30–34, 38]. However, most of these studies fo-
cused on serious bacterial sepsis or critically ill neonates.
This study aimed to characterize the NICU patients with
normal or low CRP levels at the onset of sepsis and
compared them with other neonates who had an ele-
vated CRP level. We found the differences were most
significant between neonatal BSIs in the low CRP group
and those in the high CRP (>100 mg/L) group. The non-
significant difference between the low CRP and the
intermediate CRP groups by post hoc analyses (data not
shown) implied that initial CRP level cannot be the sole
predictor of final mortality. In this study, patients in the
high CRP group treated with inappropriate antibiotics in
the first 24 h were at especially higher risk of infectious
complications and sepsis attributable mortality. How-
ever, those in the low CRP group had a relatively smooth
clinical course even though they were initially treated
with delayed effective antibiotics. Therefore, CRP still
has a reference value as an indicator of severe infection.
We found that patients with lower gestational age or
lower birth body weight tended to have a low CRP value
at the onset of BSI. Because CRP is the end product of
cytokine response after tissue injury, it is likely that ex-
tremely preterm or very low birth weight infants have less
pronounced immunomodulatory or pre-inflammatory
proteins after bacterial infection [41, 42]. Of interest,
we found this cytokine response less severe in earlier
life, but further investigation to validate these differ-
ences is required because the CRP level can also be af-
fected by various factors, including pathogens, severity
of illness, concomitant infectious focus, and some
underlying chronic comorbidities.
There are some limitations in this study. Although a
set of strict criteria was used to define true BSI, the
lack of 2 positive blood cultures for CoNS as documen-
tation of BSI is a weakness of this study. This was a
retrospective, single-center cohort study, which inevit-
ably restricts its generalizability compared to that of a
prospective, multicenter study. The timing of blood
sampling for culture and CRP also was not uniform be-
cause some septic work-up may be delayed because the
initial septic symptoms were nonspecific and subtle.
Furthermore, some CRP levels may have been falsely
low because they were obtained too early before they
started to rise around 4–6 h after sepsis onset. Lastly, a
group with elevated CRP but without infection was not
enrolled as controls. Thus, a prospective study is war-
ranted to scientifically delineate the sensitivity and specifi-
city of CRP as a predictive marker of neonatal sepsis.
Conclusion
Nearly one-forth of neonatal bloodstream infections had a
normal or low initial CRP level (<=10 mg/L), which was
more likely to occur in low birth weight or extremely
preterm infants, those with earlier onset of sepsis, and
those infected with coagulase-negative Staphylococcus.
Although initial low CRP level was significantly with less
severity of illness and better outcome, some critically ill
neonates had CRP not significantly elevated at onset of
sepsis. Therefore, plasma CRP level should not be used to
rule out severe culture-proven sepsis or guide the empir-
ical choice of antibiotics.
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